MRI在子宫内膜癌患者诊断和分期中的应用价值

The Application Value of MRI in Diagnosis andStaging of Endometrial Cancer Patients

目的:探究MRI在子宫内膜癌患者诊断和分期中的应用价值。方法:选取2019年8月至2023年8月本院收治的子宫内膜癌患者190例,所有患者均在确诊后接受手术治疗,术前利用MRI确定分期,并以手术后的病理检查结果为金标准,评估MRI在子宫内膜癌患者术前分期诊断中的准确性。结果:病理检查结果显示Ⅰ期127例,Ⅱ期47例,Ⅲ期16例;术前MRI检查结果显示Ⅰ期116例,Ⅱ期58例,Ⅲ期16例,准确度分别为91.34%、81.03%、100%;两组数据差异比较无统计学意义(P>0.05)。结论:MRI在子宫内膜癌患者分期诊断中准确性较高,与病理检查结果相比无显著性差异,具有较高的临床应用价值。

Objective:To investigate the application value of MRI in the diagnosis and staging of endometrial cancer patients.Methods:A total of 190 cases of endometrial cancer patients admitted to our hospital from August 2019 to August 2023 were selected.All patients underwent surgical treatment after confirmation of diagnosis.Preoperative MRI was used to determine the stage,with postoperative pathological examination results serving as the gold standard.The accuracy of MRI in preoperative staging diagnosis of endometrial cancer patients was evaluated.Results:Pathological examination revealed 127 cases at Stage I,47 cases at Stage II,and 16 cases at Stage III.Preoperative MRI assessments indicated 116 cases at Stage I,58 cases at Stage II,and 16 cases at Stage III,with accuracies of 91.34%,81.03%,and 100%,respectively.No statistically significant difference was found between the two sets of data(P>0.05).Conclusion:MRI demonstrates high accuracy in staging diagnosis of endometrial cancer patients,showing no significant difference compared to pathological examination results,and thus possesses considerable clinical application value.